To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

Post Category: News

September 8, 2022
Increase Cancer and Fibrosis Treatment Options Through Next Generation Sequencing

The End Brain Cancer Initiative, is thrilled to announce expansion of their mission as to increase patient disease education/awareness/outreach & access.

Read More
August 25, 2022
Announcing The ONO Pharma Prospect Trial for PCNSL

New treatment options are needed to improve the prognosis for those with primary CNS lymphoma (PCNSL). The PROSPECT study is a clinical trial to evaluate an investigational oral medicine.

Read More
August 11, 2022
Founder Dellann Speaks About The Last 20 Years At EBCI w/NW News Radio

Last month, our founder, Dellann, had an amazing discussion with host of Puget Sound Now, Bill Swartz to discuss a bit of EBCI' story.

Read More
August 4, 2022
EBCI’s Bookshop is Now Open

Visit the online EBCI bookshop to purchase from a curated list of books on brain tumors, support, cancer personal stories and much more.

Read More
July 28, 2022
Brain Cancer Spanish Website Launched by Ivy Brain Tumor Center

The Ivy Brain Tumor Center is increasing inclusion and diversity for patients through its newly launched website in Spanish.

Read More
July 21, 2022
Dr. Nader Sanai Discusses The Newest Advances In Treating GBM

On May 19th, 2022, The End Brain Cancer Initiative held our GBM "Know All Your Treatment Options" Educational, Advocacy & Outreach event. Dr. Sanai's presentation is available online.

Read More
March 28, 2022
LIVING Your Legend: by Dellann Elliott Mydland, Co-Founder, CEO, President & Board Chair

I am proud to announce our new BLOG Post Series, titled “LIVING Your Legend” in honor of celebrating 20 years of living the mission.

Read More
February 28, 2022
“Incisionless Surgery” Treatment Approach: Metabolic Targeting of GBM

This month’s CURE MAG Cover Tip brought to you by the End Brain Cancer Initiative,  and through our patient advocacy and disease education partnership with CURE, focuses on Glioblastoma Multiforme (GBM).

Read More
June 24, 2021
ASCO Annual Meeting Wrap Up

As a proud member of ASCO (American Society of Clinical Oncology), I am consistently impressed with the information they provide. They recently held their Annual Event I wanted to take the time to provide some of the incredible information and data that resulted from that meeting.

Read More
January 19, 2021
Expanded Use of Innovative Brain Tumor Treatment Exemplified in GT Medical Technologies’ 2020 GammaTile® Therapy

Exciting news from Corporate Partner GT Medical who offer a truly groundbreaking treatment for those undergoing surgery for their brain tumor in the form of safe and effective surgically targeted radiation delivered right to the tumor site.

Read More
December 19, 2020
KIYATEC – A potential game-changer in informing your brain tumor treatment decision

Groundbreaking news in the battle against brain cancer.It’s a response-prediction test which improves outcomes by testing live cancer cells against a number of potential therapies to demonstrate which ones will be most effective in killing the tumor cells.

Read More
April 6, 2020
Brain Tumor Patients and the COVID-19 Crisis – The Musella Foundation w/ Eric T. Wong, M.D.

WEBINAR! COVID-19 & BRAIN CANCER! Important information on how COVID-19 affects Brain Cancer (and other cancer) patients. Join Al Musella of the Musella Foundation and Dr. Eric T. Wong, Brain Tumor Center & Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center and Harvard Medical School.

Read More


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram